Cearvol Diamond X1 vs Otofonix Encore

The Cearvol Diamond X1 is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.7/5 in our lab testing, placing it in the top 45% of OTC devices. At $199, it represents an accessible entry point for those exploring hearing amplification. The Diamond X1's standout performance is in music streaming, scoring 4.1/5—a strong result that sits 2.18 points above the OTC category average. This makes it notably capable for users who prioritize audio entertainment through their hearing devices. Feedback handling is also excellent at 4.5/5, meaning users should experience minimal whistling during normal use. However, speech performance presents limitations. Speech in quiet scores a mixed 2.8/5, and speech in noise registers at 1.7/5. While both metrics technically sit above category averages (+0.03 and +0.22 points respectively), they remain low in absolute terms—important context for anyone prioritizing conversation clarity. Own-voice comfort is another weakness, scoring 1.7/5, which is 0.81 points below the category average and may affect how natural users sound to themselves. The Diamond X1 is best suited for budget-conscious consumers who value music streaming quality and aren't heavily reliant on challenging listening environments. Those who prioritize speech understanding in noise or natural own-voice perception may want to consider alternatives in this price range, such as the higher-scoring Elehear Beyond or Apple AirPods Pro 2.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.